Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Erythroblastosis Fetalis(Archived)

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Erythroblastosis Fetalis(Archived)

George N. Nassar et al.
Free Books & Documents

Excerpt

Hemolytic disease of the fetus and newborn (HDFN), also known as alloimmune HDFN or erythroblastosis fetalis, is caused by the destruction of red blood cells (RBCs) of the neonate or fetus by maternal immunoglobulin G (IgG) antibodies. The formation of maternal antibodies in response to a fetal antigen is called isoimmunization. These antibodies form when fetal erythrocytes with specific RBC antigens not expressed in the mother cross the placenta and gain access to maternal blood. This antibody response may be sufficient to destroy fetal red cells, leading to hemolysis, the release of bilirubin, and anemia. The severity of the illness in the fetus depends on various factors, including the amount and strength of antibodies produced by the mother, the fetus's gestational age, and the fetus's ability to replenish the destroyed RBCs and clear bilirubin.

PubMed Disclaimer

Conflict of interest statement

Disclosure: George Nassar declares no relevant financial relationships with ineligible companies.

Disclosure: Elsa Vadakekut declares no relevant financial relationships with ineligible companies.

Disclosure: Cristin Wehbe declares no relevant financial relationships with ineligible companies.

References

    1. Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med. 2008 Aug;13(4):207-14. - PubMed
    1. Gandhi MJ, Strong DM, Whitaker BI, Petrisli E. A brief overview of clinical significance of blood group antibodies. Immunohematology. 2018 Jan;33(1):4-6. - PubMed
    1. Liumbruno GM, D'Alessandro A, Rea F, Piccinini V, Catalano L, Calizzani G, Pupella S, Grazzini G. The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. Blood Transfus. 2010 Jan;8(1):8-16. - PMC - PubMed
    1. Practice Bulletin No. 181 Summary: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017 Aug;130(2):481-483. - PubMed
    1. Hartwell EA. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol. 1998 Sep;110(3):281-92. - PubMed

Publication types

LinkOut - more resources